Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
EU Medicine Authorizations 2025: A Milestone fo...
By
HEOR Staff Writer
January 20, 2026
EU Medicine Authorizations 2025: A Year of Innovation Advancements in EU Medicine Authorizations for 2025 In 2025, the European Medicines Agency (EMA) r...
Guiding Principles for Ethical AI Integration in Drug Development
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
Johnson & Johnson’s EMA Application for Teclistamab Daratumumab Th...
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
« Previous
1
2
3
4
5
6
…
32
Next »